April 8, 2022 – Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had ...
April 8, 2022 – Patients who received a transcatheter supra-annular self-expanding heart valve had significantly less ...
April 08, 2022
April 7, 2022 – Among patients undergoing non-cardiac surgery who were also on blood pressure medications, a ...
April 07, 2022
April 7, 2022 – Patients with tricuspid regurgitation, a common and debilitating form of valvular heart disease, who ...
April 07, 2022
April 7, 2022 – Patients treated with the blood thinner edoxaban for six months after a heart valve replacement ...
April 07, 2022
April 7, 2022 – The American College of Cardiology’s Global Heart Attack Treatment Initiative (GHATI) reports continuing ...
April 07, 2022
April 7, 2022 – While there are effective therapies to reduce the risk of heart disease by lowering low-density ...
April 06, 2022
April 6, 2022 – Final results from the BIO|GUARD-MI study show a 31 percent reduction of MACE in a sub-group analysis of ...
April 06, 2022
April 6, 2022 – Deaths among hospitalized patients who had both COVID-19 and the most severe type of heart attack were ...
April 06, 2022
April 6, 2022 – Donisi Health, a MedTech company working to disrupt the readmission cycle of congestive heart failure ...
April 06, 2022
April 4, 2022 – The American College of Cardiology's Evolving Practice of Cardiovascular Precision Medicine course on ...
April 04, 2022
April 4, 2022 – Esperion presented two new analyses from its clinical development program of bempedoic acid (NEXLETOL) ...
April 04, 2022
April 3, 2022 — egnite, Inc., an advanced technology digital health company focused on providing artificial intelligence ...
April 03, 2022
April 3, 2022 — A new drug shows promise in providing relief to cardiomyopathy patients experiencing shortness of breath ...
April 03, 2022
April 3, 2022 — Silence Therapeutics, a leader in the discovery, development and delivery of novel short interfering ...
April 03, 2022